Search Articles — Sudonull

https://sudonull.com/how-does-biotechnology-use-genetic-engineering

Learn how does biotechnology use genetic engineering with CRISPR, gene therapy, and more. Explore breakthroughs in medicine, agriculture, and the future of DNA editing.

https://sudonull.com/imperagen-raised-5-million-for-ai-enzymes

Startup Imperagen created a closed loop of quantum modeling, AI and robots. This accelerates R&D hundreds of times. Find out who will benefit from the breakthrough.

https://sudonull.com/ipo-conexeu-sciences-nasdaq-and-tissue-regeneration-technology

Conexeu Sciences went public on Nasdaq with no revenue but with 3D-bioprinting of breast matrix. Risk analysis, regulatory contradictions, and 90-day forecast. Read.

https://sudonull.com/moderna-s-personalized-mrna-vaccine-against-pancreatic-cancer-78-effect

Moderna released a personalized mRNA vaccine against pancreatic cancer: remission in 78% of patients over 18 months. FDA accelerated approval. Analysis of efficacy and risks.

https://sudonull.com/reqorsa-gene-therapy-analysis-of-asco-2026-data-and-prospects

Critical analysis of Reqorsa gene therapy results at ASCO-2026: sample of 18 patients, p=0.05, risks for investors and the real situation of Genprex. Read details.

https://ymaho.com/biotechnologies-in-cosmetology-exosomes-and-peptides

How exosomes and peptides replace hyaluronic acid in aesthetic medicine. Learn about real breakthroughs and marketing myths in skin regeneration. Read the review.

https://ymaho.com/alphafold-db-how-ai-predicted-200-million-proteins

DeepMind's AlphaFold database contains over 200 million protein structures. Learn how this accelerates drug discovery and transforms science. Read more in the article.

https://ymaho.com/senolytic-dasatinib-quercetin-rejuvenated-tissues-by-2-3-years

Senolytic drugs D+Q reduced biological age in humans for the first time. Learn how removing old cells rejuvenates the body. Read details of the breakthrough.

https://ymaho.com/protac-drug-vepdegestrant-approved-for-breast-cancer

FDA has approved the first PROTAC drug vepdegestrant (Veppanu) for the treatment of breast cancer. Learn how proteolysis-targeting chimera reduces the risk of progression by 43% and opens a new era in oncology.

https://ymaho.com/zilganersen-improved-walking-speed-in-alexander-disease

Antisense therapy with zilganersen shows first success in Alexander disease. Learn about phase 1-3 studies where the drug improved walking speed and stabilized patient condition.

https://ymaho.com/blood-cells-created-from-stem-cells-in-the-laboratory

Australian scientists have for the first time obtained hematopoietic stem cells in vitro. The technology promises to replace bone marrow transplantation and genetically correct blood cells. A breakthrough in hematology.

https://ymaho.com/biotechnologies-in-cosmetics-the-future-of-skincare

Learn how biotechnologies are replacing plant extracts in cosmetics. Advantages of fermentation, market forecasts, and impact on the industry. Read the article!

https://ymaho.com/human-cell-rejuvenation-therapy-trials

Learn about the first clinical trial of ER-100 cell rejuvenation therapy from Life Biosciences. How epigenetic reprogramming can reverse aging. Read details.

https://ymaho.com/epigenome-editing-of-aging-results-of-synbiobeta-2026

At SynBioBeta 2026, cell stability engineering was presented: AI mapping of aging and proteostasis editing for treating age-related diseases. Learn the details of the breakthrough.

https://ymaho.com/crispr-in-vivo-reduces-cholesterol-by-60-in-verve-102-study

Single infusion of VERVE-201 sustainably lowers LDL by more than 60%. Learn how CRISPR editing is changing the hypercholesterolemia therapy market. Read the analysis.